Barbara Perniconi
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Correction to "Nanoengineered Osteoinductive and Elastomeric Scaffolds for Bone Tissue Engineering".
Correction to "Nanoengineered Osteoinductive and Elastomeric Scaffolds for Bone Tissue Engineering".
Journal: ACS biomaterials science & engineering
Published: October 20, 2025
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
Journal: EBioMedicine
Published: February 18, 2022
Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease.
Journal: Neurology
Published: February 15, 2019
Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.
Journal: Journal of inherited metabolic disease
Published: February 11, 2018
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease.
Journal: Molecular genetics and metabolism
Published: May 30, 2017
Nanoengineered Osteoinductive and Elastomeric Scaffolds for Bone Tissue Engineering.
Journal: ACS biomaterials science & engineering
Published: April 10, 2017
Multidisciplinary care allowing uneventful vaginal delivery in a woman with Pompe disease.
Journal: Neuromuscular disorders : NMD
Published: February 05, 2016
Muscle extracellular matrix scaffold is a multipotent environment.
Journal: International journal of medical sciences
Published: October 08, 2014
Skeletal muscle tissue engineering: best bet or black beast?
Journal: Frontiers in physiology
Published: April 08, 2014
Muscle acellular scaffold as a biomaterial: effects on C2C12 cell differentiation and interaction with the murine host environment.
Journal: Frontiers in physiology
Published: April 02, 2014
Native extracellular matrix: a new scaffolding platform for repair of damaged muscle.
Journal: Frontiers in physiology
Published: February 21, 2014
Last Updated: 09/26/2026